
OBDS- On Body Delivery System
Products


Information
Designed with both patient and pharma in mind, the SorrelTM OBDS wearable platform is digitally integrated to deliver greater data for the pharma eco-system and enable better adherence for the patient. Based on our patents and ground-breaking design, Sorrel(TM)is suited for multiple configurations, molecules, and indications to enable smart, reliable, simple drug delivery at home.Intuitive for the patient, our platform enables pharma partners to mitigate the risks associated with original development including safety, efficacy, cost and time to market.The SorrelTM OBDS is no longer an engineering concept. The first product has been successfully launched in 2024.
